KX2-361
CAS No. 897016-26-1
KX2-361( KX-2361 | KX-02 )
Catalog No. M16453 CAS No. 897016-26-1
KX2-361 (KX 02) is a potent, dual Src signaling/tubulin polymerization inhibitor that are under clinical evaluation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 302 | Get Quote |
|
10MG | 447 | Get Quote |
|
25MG | 714 | Get Quote |
|
50MG | 1017 | Get Quote |
|
100MG | 1368 | Get Quote |
|
500MG | 2673 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameKX2-361
-
NoteResearch use only, not for human use.
-
Brief DescriptionKX2-361 (KX 02) is a potent, dual Src signaling/tubulin polymerization inhibitor that are under clinical evaluation.
-
DescriptionKX2-361 (KX 02) is a potent, dual Src signaling/tubulin polymerization inhibitor that are under clinical evaluation.Brain Cancer Phase 1 Clinical.
-
SynonymsKX-2361 | KX-02
-
PathwayCancer
-
TargetBrain Cancer
-
RecptorSrc
-
Research AreaCancer
-
IndicationBrain Cancer
Chemical Information
-
CAS Number897016-26-1
-
Formula Weight405.473
-
Molecular FormulaC24H24FN3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NCC1=CC=CC(F)=C1)CC2=NC=C(C3=CC=C(N4CCOCC4)C=C3)C=C2
-
Chemical NameN-(3-fluorobenzyl)-2-(5-(4-morpholinophenyl)pyridin-2-yl)acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Smolinski MP, et al. J Med Chem. 2018 Apr 17. doi: 10.1021/acs.jmedchem.8b00164.
molnova catalog
related products
-
AEE-788
A potent, orally bioavailable dual EGFR/VEGFR receptor tyrosine kinase inhibitor with IC50 of 2, 6, 77 and 59 nM for EGFR, ErbB2, KDR and Flt-1, respectively.
-
Tandutinib
A potent inhibitor of FLT3, Kit and PDGFR with IC50 of 0.22, 0.17 and 0.2 uM, respectively.
-
S49076
S49076 is a potent, ATP-competitive tyrosine kinase inhibitor of MET, AXL/MER, and FGFR1/2/3 with IC50 of <20 nM.